Neil Sengupta to Risk Assessment
This is a "connection" page, showing publications Neil Sengupta has written about Risk Assessment.
Connection Strength
1.215
-
Integrating Gastrointestinal Bleeding Risk Scores into Clinical Practice. Am J Gastroenterol. 2019 11; 114(11):1699-1703.
Score: 0.417
-
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. PLoS One. 2016; 11(2):e0147237.
Score: 0.323
-
Risk Stratification of Angioectasia as a Cause of Gastrointestinal Bleeding: Untangling the Spider's Web? Dig Dis Sci. 2019 10; 64(10):2693-2695.
Score: 0.104
-
Comparison of clinical prediction tools and identification of risk factors for adverse outcomes in acute lower GI bleeding. Gastrointest Endosc. 2019 05; 89(5):1005-1013.e2.
Score: 0.098
-
Resumption of Warfarin After Hospitalization for Lower Gastrointestinal Bleeding and Mortality Benefits. J Clin Gastroenterol. 2018 07; 52(6):545-550.
Score: 0.095
-
High Glasgow Blatchford Score at admission is associated with recurrent bleeding after discharge for patients hospitalized with upper gastrointestinal bleeding. Endoscopy. 2016 Jan; 48(1):9-15.
Score: 0.078
-
Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1670-5.
Score: 0.076
-
A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. Hepatology. 2018 10; 68(4):1498-1507.
Score: 0.024